These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9111077)

  • 21. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
    Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion-protein-specific aptamer reduces PrPSc formation.
    Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
    Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative binding of dominant-negative prion protein to kringle domains.
    Ryou C; Prusiner SB; Legname G
    J Mol Biol; 2003 May; 329(2):323-33. PubMed ID: 12758079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology and genetics of prion diseases.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein amyloid: separation of scrapie infectivity from PrP polymers.
    Wille H; Baldwin MA; Cohen FE; DeArmond SJ; Prusiner SB
    Ciba Found Symp; 1996; 199():181-99; discussion 199-201. PubMed ID: 8915611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
    Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and trafficking of prion proteins in cultured cells.
    Taraboulos A; Raeber AJ; Borchelt DR; Serban D; Prusiner SB
    Mol Biol Cell; 1992 Aug; 3(8):851-63. PubMed ID: 1356522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
    Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
    Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity.
    Shaked GM; Fridlander G; Meiner Z; Taraboulos A; Gabizon R
    J Biol Chem; 1999 Jun; 274(25):17981-6. PubMed ID: 10364247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance.
    Gauczynski S; Krasemann S; Bodemer W; Weiss S
    J Cell Sci; 2002 Nov; 115(Pt 21):4025-36. PubMed ID: 12356908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonication induced intermediate in prion protein conversion.
    Zukas AA; Bruederle CE; Carter JM
    Protein Pept Lett; 2008; 15(2):206-11. PubMed ID: 18289112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.